Table 1

Effect of PGF2α on the expression of genes related to the extracellular matrix (ECM).

Gene Bank number
Swiss protein number
Name
Function
Ratio
% decrease
Fold increase

U65656
P97581
Gelatinase A
Metalloproteinase
0.04 ± 0.02
87.53

Y00697
P07154
Cathepsin L
Cysteine protease
0.09 ± 0.05
91.09

L31884
P30121
Tissue inhibitor metalloproteinase 2 (TIMP2)
Protease inhibitor
0.05 ± 0.01
95.54

U27201
P48032
Tissue inhibitor metalloproteinase 3 (TIMP3)
Protease inhibitor
0.04 ± 0.01
91.95

X63434
P29598
Urokinase type Plasminogen activator (uPA)
Serine protease
0.14 ± 0.09
94.86

M24067
P20961
Plasminogen activator inhibitor (PAI)
Protease inhibitor
0.09 ± 0.05
91.68

M2367
P19367
Tissue type plasminogen activator (tPA)
Serine protease
0.17 ± 0.02
89.90

X71071
Q08290
Calponin
Cytoskeleton
0.08 ± 0.004
92.50

U06755
P37397
Calponin, acidic
Cytoskeleton
0.24 ± 0.13
76.76

U62897
O35850
Carboxypeptidase D
Carboxypeptidase
0.24 ± 0.14
76.48

M64711
P22388
Endothelin 1
Hormone
0.34 ± 0.2
77.48

X02601
P03957
Polypeptide, 53 kDa, growth factor induced
Metalloproteinase
2.54 ± 1.04

3
J03552
P14046
Plasma proteinase inhibitor α1-inhibitor III
Protease inhibitor
3.64 ± 0.64

4
M32247
P17475
α1 antiproteinase
Protease inhibitor
2.45 ± 0.44

3

Ratio = net intensity of PGF2α normalized/net intensity of control normalized, and represent the mean ± SEM of each ratio from separate experiments. Ratio > 2 = up regulation; ratio < 0.5 = down regulation; 0.5 < Ratio < 2 = equal expression.

Callegari et al. Reproductive Biology and Endocrinology 2005 3:3   doi:10.1186/1477-7827-3-3